Anabolic therapies for osteoporosis [18]

New England Journal of Medicine

Volumn 357, Issue 23, 2007, Pages 2410-2411

  Farooki, Azeez ^a   Fornier, Monica ^a   Girotra, Monica ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PARATHYROID HORMONE[1-34];

BONE MARROW; BONE MARROW METASTASIS; BREAST CANCER; HUMAN; LETTER; LUNG NON SMALL CELL CANCER; MICROMETASTASIS; OSTEOBLAST; OSTEOCLAST; OSTEOPOROSIS; PRIORITY JOURNAL; TREATMENT CONTRAINDICATION;

EID: 36849090628     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc076405     Document Type: Letter

References (5)

1. Canalis E, Giustina A, Bilezikian JP. Mechanisms of anabolic therapies for osteoporosis. N Engl J Med 2007;357:905-16.
2. Cote RJ, Beattie EJ, Chaiwun B, et al. Detection of occult bone marrow micrometastases in patients with operable lung carcinoma. Ann Surg 1995;222:415-25.
3. Braun S, Vogl FD, Naume B, et al. A pooled analysis of bone marrow micrometastasis in breast cancer. N Engl J Med 2005;353:793-802.
4. Whitfield JF. Parathyroid hormone: a novel tool for treating bone marrow depletion in cancer patients caused by chemotherapeutic drugs and ionizing radiation. Cancer Lett 2006;244:8-15.
5. Scadden DT. The stem cell niche in health and leukemic disease. Best Pract Res Clin Haematol 2007;20:19-27.